Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06549504
PHASE1
Bioequivalence Study of AG2202
Sponsor: Ahn-Gook Pharmaceuticals Co.,Ltd
View on ClinicalTrials.gov
Summary
The objective of this study is to evaluate the human bioequivalence of AG2202T and AG2202R.
Official title: An Open-label, Randomized, Fasting, Single, Oral Administration, Group 2, Stage 2, Cross-over Bioequivalence Study of AG2202 in Healthy Volunteers
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
INTERVENTIONAL
Enrollment
34
Start Date
2024-08
Completion Date
2024-09
Last Updated
2024-08-14
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
AG2202T
AG2202T Single-dose
DRUG
AG2202R
AG2202R Single-dose